Becton, Dickinson and Company Stock
Becton, Dickinson and Company
Company data
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Country
- United States
- CEO
- Thomas E. Polen Jr.
- Employees
- 72,000
- Market cap
- $52.2 B
- IPO
- 21/02/1973
- Web
- www.bd.com
Operating globally, Becton, Dickinson and Company is a prominent enterprise in the Healthcare sector focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. Established in 1897, the company is headquartered in Franklin Lakes, USA, and employs approximately 72,000 people.…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
Becton, Dickinson and Company stock: price history
1D
-1.0%
1W
+4.4%
1M
+5.4%
6M
+20.9%
YTD
+25.7%
1Y
+31.7%
2Y
+1.5%
5Y
+3.7%
10Y
+45.4%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~101% stronger price swings than usual
Pattern chart
Pattern detected by the Market Jury detector vsqueeze-release-v1.0 on 12/10/26. Not a buy or sell signal.Beta
What does this mean?
Volatility squeeze
BullishPrice swings had compressed unusually tight beforehand (volatility near a low) and are now releasing into a stronger move. Technical analysis views such tight phases as often preceding a bigger move.
Chart patterns are a purely technical signal derived from price action. At Market Jury they do not feed into the agents' buy or sell decisions, they are supplementary information only.
Becton, Dickinson and Company stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 17/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
2 more assignments (Enabler/Second row) Pro-only.
Becton, Dickinson and Company is a globally operating medical technology company focused on the development, manufacturing, and distribution of medical technologies. The portfolio comprises three main segments: Medical, which provides solutions for medication management such as catheters and syringes; Life Sciences, specializing in diagnostic tools and research equipment; and Interventional, offering surgical products for interventional procedures. The customer base includes medical facilities, research institutions, and pharmaceutical companies. The business model is primarily based on the sale of medical supplies, distributing both highly specialized equipment and recurring consumables such as reagents and disposable items.
- Revenue model
- Transactional
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Wide
- Moat type
- Switching costs
- Capital intensity
- High
- Customer concentration
- Unknown
Ask the agents about Becton, Dickinson and Company
Analyst assessment of Becton, Dickinson and Company
PRICE TARGET LOW
US$159.00
CONSENSUS
US$184.14
MEDIAN
US$190.00
PRICE TARGET HIGH
US$210.00
0
STRONG BUY
16
BUY
17
HOLD
1
SELL
0
STRONG SELL
34
TOTAL · Hold
As of: 31/08/2026
Becton, Dickinson and Company stock metrics
P/E
57.76
P/B
2.16
EV/EBITDA
15.32
RETURN ON EQUITY
1.5%
NET MARGIN
7.6%
DEBT/EQUITY
0.69
DIVIDEND YIELD
2.1%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
99.8%
FLOAT SHARES
271,830,241
AVG. DAILY VOLUME (30D)
1,770,068
Insider transactions (SEC)
Feld Michael
Roque Vitor
Feld Michael
Feld Michael
Polen Thomas E Jr
Institutional holders
Dividends & Stock splits
Dividends
Stock splits
Comparable stocks
Frequently asked questions about Becton, Dickinson and Company stock
What does Becton, Dickinson and Company do?
Becton, Dickinson and Company is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United States.
The CEO is Thomas E. Polen Jr., the company employs around 72,000 people.
The IPO was on 21/02/1973; the stock trades on NYSE under the ticker BDX.
What do analysts say about Becton, Dickinson and Company stock?
34 analysts rate the stock, the consensus is Hold (as of 31/08/2026).
The average price target is US$184.14, ranging from US$159.00 to US$210.00, with a median of US$190.00.
This is an external assessment, not a statement by Market Jury.
When does Becton, Dickinson and Company report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 101% stronger than usual.
Does Becton, Dickinson and Company pay a dividend?
Yes. The last dividend was US$1.05 per share, ex-date 09/09/2026, paid on 30/09/2026.
The dividend yield is 2.1% (as of 30/06/2026).
Which stocks are comparable to Becton, Dickinson and Company?
Comparable stocks include Intuitive Surgical, ResMed, West Pharmaceutical Services, Solventum, Baxter International, Cooper Companies, Avantor and Repligen.
How can I get Becton, Dickinson and Company stock analyzed?
Clicking "Analyze stock" lets five strategies assess Becton, Dickinson and Company against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.